Cabergoline is a potent dopamine agonist primarily used in the treatment of conditions related to hyperprolactinemia, such as prolactinomas and other disorders leading to excessive prolactin secretion. It is classified as a D2 receptor agonist, which mimics the action of dopamine in the brain, thereby inhibiting prolactin release from the anterior pituitary gland. The typical dosage of cabergoline for these conditions is often 0.25 mg, taken twice weekly.
https://vipamobler.dk/2026/03/04/understanding-the-pharmacological-action-of-cabergoline-0-25-mg/
Pharmacological Action
The pharmacological action of cabergoline can be summarized as follows:
- Dopamine Receptor Agonism: Cabergoline acts predominantly on D2 dopamine receptors, leading to the inhibition of prolactin secretion.
- Reduced Prolactin Levels: By activating dopamine receptors, cabergoline effectively lowers plasma prolactin levels, which can alleviate symptoms associated with hyperprolactinemia.
- Therapeutic Uses: It is utilized in the treatment of conditions such as amenorrhea, galactorrhea, and infertility caused by elevated prolactin levels.
- Side Effects: Common side effects include nausea, headache, and dizziness, largely due to its central nervous system effects.
Apart from its use in treating hyperprolactinemic states, cabergoline has also been investigated for its potential benefits in other conditions, such as Parkinson’s disease, due to its stimulatory effects on the dopaminergic system.
Overall, cabergoline 0.25 mg serves as an effective pharmacological agent for managing conditions linked to high prolactin levels, providing symptomatic relief and improving patient quality of life.